Versandkostenfrei ab 29,00 €

Produktinformationen "Animal Models for the Development of Cancer Immunotherapy"

Animal Models for the Development of Cancer Immunotherapy Provides readers with a clear understanding of the value and challenges of using common and emerging preclinical models in cancer immunotherapy research and development. Animal models are essential tools for studying a range of issues in preclinical and clinical research on therapies targeting cancerous tumors. As clinical trials of advances in cancer immunotherapy are predicted to outpace preclinical research in the near future, there remains an urgent need to develop better animal models for preclinical evaluation of novel modulators. Animal Models for the Development of Cancer Immunotherapy provides a detailed overview of different preclinical model systems for development of novel cancer immunotherapies while highlighting how key aspects of individual models translate into clinical findings. Covering the introduction, development, and therapeutic applications of animal models for cancer immunotherapy, this comprehensive volume helps pharmacologists identify suitable animal models, design pharmacological or translational studies, and advance their mechanistic understanding of therapeutic agents, and increase the possibility of success for novel immunotherapies in clinical settings. Chapters written by prominent leaders in the field address specific models that evaluate immuno-oncology drugs are supported by in-depth case studies and extensive references throughout. - Emphasizes the importance of modeling tumor metastasis in preclinical models for efficient translation of findings into the clinic - Explores recently discovered mechanisms of resistance and their preclinical modeling - Highlights the unique characteristics and features of autologous and allogeneic approaches for humanization of mouse models - Reviews development of bone marrow-liver-thymus (BLT) immune humanized mice and emerging alternative models such as genetically engineered mouse models (GEMM) - Discusses alternative animal models for cancer research such as severe combined immunodeficiency (SCID) pigs Animal Models for the Development of Cancer Immunotherapy is an essential resource for scientists and researchers in the pharmaceutical and biotechnology industries, medicinal chemists and biochemists, cell and molecular biologists, pharmacologists, immunologists, and clinicians.

H | B | T | Gramm
235 mm | 157 mm | 21 mm | 0.61 kg

Erscheinungsjahr
2022

FSK
0

Ausgabe
Hardcover

Verlag
John Wiley Sons

ISBN-10
111953528x

ISBN-13
9781119535287

Autor
Seng-Lai Tan

Sprache
Englisch

Seitenanzahl
320

Verantwortliche Person gemäß Art. 16 GPSR
Wiley-VCH GmbH, Boschstrasse 12, 69469, Weinheim, DE, product_safety@wiley.com

0 von 0 Bewertungen

Durchschnittliche Bewertung von 0 von 5 Sternen

Bewerten Sie dieses Produkt!

Teilen Sie Ihre Erfahrungen mit anderen Kunden.


Seng-Lai Tan

Autor/in

Seng-Lai Tan

Seng-Lai Tan, PhD, is Chief Scientific Officer at Immunitas Therapeutics. He has more than 20 years of drug discovery and development experience in both small and large molecule therapeutic modalities, including multi-specific antibodies and stapled peptides. He is former Head of Immunology at Marengo (Elstar) Therapeutics and Forma Therapeutics, and has held leadership positions at EMD Serono Research & Development Institute and Roche.

Wusstest du, dass...

ein wiederverkauftes Buch rund 2,7 kg CO₂ einspart – das entspricht einer 14 km langen Autofahrt?

Erfahre mehr zum Thema Nachhaltigkeit bei Buchpark

Versandkostenfrei ab 29 €

14 Tage Rückgaberecht - Kein Risiko

Geprüfte Gebrauchtware

Filter werden angewendet...